Pfizer-BioNTech COVID-19 vaccine curbs transmission, Israeli analysis suggests


Data from Israel that are awaiting publication suggest the Pfizer-BioNTech COVID-19 vaccine is not only effective at preventing symptomatic infection, but can also stop transmission of the virus in the first place, The Financial Times and Bloomberg reported Sunday.
The potentially game-changing results were compiled by the health ministry in Israel, the country with the world's highest vaccination rate, in the three weeks leading up to Feb. 6. By the end of that period, more than 27 percent of the over-15 Israeli population had been fully vaccinated, and the preliminary real-world observation analysis found the vaccine was 89 percent effective at preventing infection of any kind.
As is often the case with studies during the coronavirus pandemic, the findings require more scrutiny, but they are in line with those of a similar analysis conducted by the Mayo Clinic. That study looked at 31,000 people across four U.S. states who received at least one dose of either vaccine, determining they were around 80 percent effective at preventing infection 36 days after the initial dose, CNN reports. Read more at The Financial Times and Bloomberg.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
What's next for Elon Musk?
Today's Big Question The world's richest man has become 'disillusioned' with politics – but returning to his tech empire presents its own challenges
-
Quiz of The Week: 24 – 30 May
Have you been paying attention to The Week's news?
-
The Week Unwrapped: Will Europe beat China and India to the North Pole?
Podcast Plus, is the man who designed the iPhone going to kill his own creation? And what's going on at the equalities watchdog?
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows